GeezerVisonThe World Wide Web, restored to 800 pixels of glory. |
| Home|About|Gaming cabinet|Archives|How it works|Starter sites |
GeezerVison is showing finance.yahoo.com — SpyGlass Pharma, Inc. (SGP) Stock Price, News, Quote & History - Yahoo Finance NasdaqGS - Delayed Quote • USD SpyGlass Pharma, Inc. (SGP) 34.97 +0.79 (+2.31%) At close: November 11 at 4:00:00 PM EST 34.97 0.00 (0.00%) Chart Range Bar Loading chart for SGP
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California. www.spyglasspharma.comTrailing total returns as of 11/11/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) . SGP 45.71% S&P 500 (^GSPC) 11.30% SGP 45.71% S&P 500 (^GSPC) 11.29% SGP 45.71% S&P 500 (^GSPC) 72.57% SGP 45.71% S&P 500 (^GSPC) 63.88%
Profitability and Income Statement
Balance Sheet and Cash Flow
|
| You are visitor 01402503 — GeezerVison does not store the pages you look up. Best viewed with Netscape Navigator 4.7 or Internet Explorer 6 at 800×600. No cookies required. |
